TOKYO – For decades, the US enjoyed a remarkable luxury: its two biggest creditors, Japan and China, kept showing up at Treasury auctions with checkbooks open. Now, Donald Trump’s trade wars, tariff threats and widening geopolitical confrontations raise an uncomfortable question: what happens if Washington’s most reliable bankers decide they’ve had enough? Granted, global investors […] The post…
French envoy Gérard Mestrallet said IMEC’s financing model cannot be compared with China’s BRI, as the two projects follow fundamentally different approaches.
Japan Exchange Group Inc. is set to unveil the biggest-ever reshuffle of the Topix on Wednesday, a revamp that could shrink one of Asia’s broadest major equity benchmarks and intensify pressure on…
US firm ArriVent BioPharma’s shares plummeted after a late-stage trial failure involving a cancer drug licensed from China, a setback that analysts said highlighted the challenges facing Chinese biotech companies expanding overseas.
